recombinant vaccine based on virus-like particles (Cytos Biotechnology AG)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant vaccine based on virus-like particles (Cytos Biotechnology AG)
Drug Alias Namerecombinant Ara h 1 and Ara h 2 vaccine (Cytos Biotechnology AG)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPeanut Hypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKuros Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuros Biosciences
Active IndicationsN/A
Inactive IndicationsPeanut Hypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A